CoDa Therapeutics raises $19.8 mn from Russian firm
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Aug, 2012
Singapore: CoDa Therapeutics has raised an additional $19.8 million (NZ$24.5 million) from Russian investment firm Rusna...Read more
Chugai seeks nod for breast cancer drug in Japan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 01 Feb, 2013
Singapore: Japanese multinational Chugai Pharmaceutical has filed a new drug application to the Ministry of Health, Labo...Read more
Viralytics presents +ve results of phase II Cavatak trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 19 Jul, 2013
Singapore: Viralytics reported strong interim results from its phase II clinical trial of Cavatak treatment in late stag...Read more
Competition intensifies for type 2 diabetes drugs
Drug Discovery | Analysis | By BioSpectrum Bureau | 0 Comment | 28 Aug, 2013
Singapore: The global pre-diabetes population is three times the size of the current diabetes patient population and the...Read more
FDA approval gives new hope to Multiple Sclerosis patients
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 13 Sep, 2012
Singapore: Genzyme, a Sanofi company, received approval from the US FDA for AUBAGIO (teriflunomide) as a new once-daily,...Read more
TaiGen files NDA for Nemonoxacin in Taiwan, China
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 16 May, 2013
Singapore: Taiwan's TaiGen Biotechnology has submitted New Drug Application (NDA) for the oral formulation of nemonoxaci...Read more
Verinata Health joins hands with Teva in Israel
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 02 Jul, 2013
Singapore: Illumina announced that Teva Pharmaceutical has signed an exclusive agreement with Verinata Health, an Illumi...Read more
Merck Serono starts Phase III non-small cell lung cancer drug trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Apr, 2014
Singapore: Global biopharmaceutical firm Merck Serono has initiated international Phase III trial of its investigational...Read more
Pradaxa gets EU approval for DVT
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 10 Jun, 2014
Singapore: Boehringer Ingelheim has recieved Euroean approval for Pradaxa (dabigatran etexilate) for the treatment and p...Read more
AstraZeneca, LegoChem drug to curb superbugs
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Dec, 2012
Singapore: AstraZeneca has formed collaboration with Korea's LegoChem Biosciences to develop a novel antibiotic to treat...Read more
Big pharma yet to warm up to drug resistance
Drug Discovery | Analysis | By BioSpectrum Bureau | 0 Comment | 01 Jun, 2012
Singapore: Drug resistance and patent expiries are demanding that the antibacterial drug market moves forward soon, but ...Read more
Cancer Therapeutics reveals new targeted drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 05 Jul, 2012
Singapore: Cancer Therapeutics, an Australian company focused on translating cancer biology research into novel treatmen...Read more
Eisai gets WHO prequalification, will donate 2.2 bn doses
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 03 Sep, 2013
Singapore: The WHO has prequalified Eisai's drug NTD002, a 100 mg tablet of diethylcarbamazine (DEC) for treatment of el...Read more
Bayer and Sanofi battle to cure colorectal cancer
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Oct, 2012
Singapore: Bayer's Stivarga (regorafenib) became the second drug to have been approved in the past two months by the US ...Read more
New antibody-based drug to cure diabetes
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 27 Sep, 2012
Singapore: CSL has developed a new drug candidate that is able to prevent the development of type 2 diabetes and revers...Read more
Novartis oncology president steps down
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 13 Jan, 2014
Singapore: Novartis oncology president, Mr Hervé Hoppenot, has stepped down from the position to pursue a career oppo...Read more
Hodgkin lymphoma therapy may lead to other cancers
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 27 Aug, 2013
Singapore: Hodgkin lymphoma survivors, who received certain radiation and chemotherapy regimens, were at increased risk ...Read more
Phase III data: STELARA reduces active psoriatic arthritis
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 06 Jun, 2012
Singapore: A study by Janssen Research and Development revealed that patients with active psoriatic arthritis, who were ...Read more